View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cetuximab 250 / Radiation, Squamous Cell Carcinoma of the Skin, Cycle 2+
Protocol-ID: 2164 V1.0 (Mini), CETU250/Radiation, CSCC, C2+Indication(s)
- Squamous Cell Carcinoma of the Skin; ICD-10 C44.9
ST Radiotherapy: simultaneous Radiation |
| From cycle 2: Irradiation up to a total dose of 55-66 Gy in 22-30 fractions. |
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.10.2022